Current Status of Blood Transfusion and Antifibrinolytic Therapy in Orthopedic Surgeries

Frontiers in Surgery

Volumn 2, Issue , 2015, Pages

  Stoicea, Nicoleta ^a   Bergese, Sergio D ^a   Ackermann, Wiebke ^a   Moran, Kenneth R ^a   Hamilton, Charles ^a   Joseph, Nicholas ^b   Steiner, Nathan ^c   Barnett, Christopher J ^d   Smith, Stewart ^e   Ellis, Thomas J ^f  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f Orthopedic One   (United States)

Author keywords

blood transfusion; direct anterior approach (DAA); erythropoiesis stimulating agents (ESAs); posterior approach (PA); total hip arthroplasty; tranexamic acid (TXA)

Indexed keywords

EID: 85015163398     PISSN: None     EISSN: 2296875X     Source Type: Journal    
DOI: 10.3389/fsurg.2015.00003     Document Type: Note

References (34)

1. Amlie E, Havelin LI, Furnes O, Baste V, Nordsletten L, Hovik O, et al. Worse patient-reported outcome after lateral approach than after anterior and posterolateral approach in primary hip arthroplasty. Acta Orthop (2014) 85(5):1–7.10.3109/17453674.2014.93418324954494
2. Martin CT, Pugely AJ, Gao Y, Clark CR. A comparison of hospital length of stay and short-term morbidity between the anterior and the posterior approaches to total hip arthroplasty. J Arthroplasty (2013) 28(5):849–54.10.1016/j.arth.2012.10.02923489731
3. Palan J, Beard DJ, Murray DW, Andrew JG, Nolan J. Which approach for total hip arthroplasty: anterolateral or posterior? Clin Orthop Relat Res (2009) 467(2):473–7.10.1007/s11999-008-0560-518941858
4. Sculco TP. Anterior approach in the improves outcomes: opposes. Orthopedics (2011) 34(9): e459–61.10.3928/01477447-20110714-2921902130
5. Barton C, Kim PR. Complications of the direct anterior approach for total hip arthroplasty. Orthop Clin North Am (2009) 40(3):371–5.10.1016/j.ocl.2009.04.00419576405
6. Christensen CP, Karthikeyan T, Jacobs CA. Greater prevalence of wound complications requiring reoperation with direct anterior approach total hip arthroplasty. J Arthroplasty (2014) 29(9):1839–41.10.1016/j.arth.2014.04.03624890998
7. Rodriguez JA, Deshmukh AJ, Rathod PA, Greiz ML, Deshmane PP, Hepinstall MS, et al. Does the direct anterior approach in THA offer faster rehabilitation and comparable safety to the posterior approach? Clin Orthop Relat Res (2013) 472(2):455–63.10.1007/s11999-013-3231-023963704
8. Rathod PA, Orishimo KF, Kremenic IJ, Deshmukh AJ, Rodriguez JA. Similar improvement in gait parameters following direct anterior & posterior approach total hip arthroplasty. J Arthroplasty (2014) 29(6):1261–4.10.1016/j.arth.2013.11.02124405621
9. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am (1999) 81(1):2–10.
10. Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion (2005) 45(1):103–10.10.1111/j.1537-2995.2005.04149.x15647025
11. Monsef JB, Perna M, Boettner F. Management of blood products in orthopedic surgery. In: Perioperative Care of the Orthopedic Patient. New York: Springer (2014). p. 311–30.
12. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet (2003) 361(9352):161–9.10.1016/S0140-6736(03)12195-2
13. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br (2008) 90(9):1128–36.10.1302/0301-620X.90B9.2111518757950
14. Schweppe ML, Seyler TM, Plate JF, Swenson RD, Lang JE. Does surgical approach in total hip arthroplasty affect rehabilitation, discharge disposition, and readmission rate? Surg Technol Int (2013) 23:219–27.23700180
15. Barrett WP, Turner SE, Leopold JP. Prospective randomized study of direct anterior vs. postero-lateral approach for total hip arthroplasty. J Arthroplasty (2013) 28(9):1634–8.10.1016/j.arth.2013.01.034
16. Higgins BT, Barlow DR, Heagerty NE, Lin TJ. Anterior vs. posterior approach for total hip arthroplasty, a systematic review and meta-analysis. J Arthroplasty (2014).10.1016/j.arth.2014.10.02025453632
17. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty (2013) 28(8 Suppl):34–7.10.1016/j.arth.2013.03.03523896359
18. Voorn VM, Marang-van de Mheen PJ, Wentink MM, Kaptein AA, Koopman-van Gemert AW, So-Osman C, et al. Perceived barriers among physicians for stopping non-cost-effective blood-saving measures in total hip and total knee arthroplasties. Transfusion (2014) 54(10 Pt 2):2598–607.10.1111/trf.1267224797267
19. Couvret C, Laffon M, Baud A, Payen V, Burdin P, Fusciardi J. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty. Anesth Analg (2004) 99(1):262–71.10.1213/01.ANE.0000118165.70750.7815281542
20. Francis JJ, Tinmouth A, Stanworth SJ, Grimshaw JM, Johnston M, Hyde C, et al. Using theories of behaviour to understand transfusion prescribing in three clinical contexts in two countries: development work for an implementation trial. Implement Sci (2009) 4:70.10.1186/1748-5908-4-7019852832
21. Borghi B, Casati A. Incidence and risk factors for allogeneic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol (2000) 17(7): 411–7.10.1046/j.1365-2346.2000.00693.x
22. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am (2014) 96(4):272–8.10.2106/JBJS.L.01268
23. Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, et al. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am (2014) 96(4):279–84.10.2106/JBJS.L.01041
24. McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs (2012) 72(5):585–617.10.2165/11209070-000000000-0000022397329
25. Huang F, Wu D, Ma G, Yin Z, Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res (2014) 186(1):318–27.10.1016/j.jss.2013.08.02024075404
26. Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement. J Bone Joint Surg Am (2013) 95(21):1961.10.2106/JBJS.L.0090724196466
27. Huang Z, Ma J, Shen B, Pei F. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty (2014) 29(12):2342–6.10.1016/j.arth.2014.05.02625007725
28. Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents – time for a reevaluation. N Engl J Med (2010) 362(3):189–92.10.1056/NEJMp0912328
29. Alsaleh K, Alotaibi GS, Almodaimegh HS, Aleem AA, Kouroukis CT. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty. J Arthroplasty (2013) 28(9):1463–72.10.1016/j.arth.2013.01.02423528548
30. Yoshihara H, Yoneoka D. National trends in the utilization of blood transfusions in total hip and knee arthroplasty. J Arthroplasty (2014) 29(10):1932–7.10.1016/j.arth.2014.04.02924890994
31. Robinson S, McGonigle O, Volin S, Sung YC, Moore M, Cassidy C, et al. Comprehensive look at blood transfusion utilization in total joint arthroplasty at a single academic medical center under a single surgeon. J Blood Transfus (2013) 2013:983250.10.1155/2013/98325024089654
32. Spahn DR. Anemia and patient blood management in hip and knee surgery. Anesthesiology (2010) 113(2):482–95.10.1097/ALN.0b013e3181e08e9720613475
33. Horstmann WG, Ettema HB, Verheyen CC. Dutch orthopedic blood management surveys 2002 and 2007: an increasing use of blood-saving measures. Arch Orthop Trauma Surg (2010) 130(1):55–9.10.1007/s00402-009-0910-019529950
34. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med (2011) 365(26):2453–62.10.1056/NEJMoa101245222168590